Implementation of a pharmacogenomics service in a community pharmacy von Ferreri, Stefanie P., PharmD, CPP, BCACP, CDE, FAPhA, Greco, Angelo J., PharmD, Michaels, Natasha M., PharmD, CPP, BCACP, O’Connor, Shanna K., PharmD, BCPS, Chater, Rebecca W., BSPharm, MPH,FAPhA, Viera, Anthony J., MD, MPH, Faruki, Hawazin, McLeod, Howard L., PharmD,FCCP, Roederer, Mary W., PharmD, BCPS

Volltext

Polymorphism of ORM1 is associated with the pharmacokinetics of telmisartan von Chen, Wang-Qing, Shu, Yan, Li, Qing, Xu, Lin-Yong, Roederer, Mary W, Fan, Lan, Wu, Lan-Xiang, He, Fa-Zhong, Luo, Jian-Quan, Tan, Zhi-Rong, He, Yi-Jing, Zhou, Hong-Hao, Chen, Xiang, Zhang, Wei

Volltext

Pharmacogenomics competencies in pharmacy practice: A blueprint for change von Roederer, Mary W, Kuo, Grace M, Kisor, David F, Frye, Reginald F, Hoffman, James M, Jenkins, Jean, Weitzel, Kristin Wiisanen

Volltext

Can pharmacogenomics improve malaria drug policy? von ROEDERER, Mary W, MCLEOD, Howard, JULIANO, Jonathan J

Volltext

Pharmacists and pharmacogenetics von Roederer, Mary W

Volltext

Can pharmacogenomics improve malaria drug policy? von Roederer, Mary W, McLeod, Howard, Juliano, Jonathan J

Volltext

An evaluation of pharmacogenomic information provided by five common drug information resources von VAUGHAN, K. T. L, SCOLARO, Kelly L, ANKSORUS, Heidi N, ROEDERER, Mary W

Volltext

Global Formulary Review: How Do We Integrate Pharmacogenomic Information? von Poppe, Lindsey B, Roederer, Mary W

Volltext

Risks and Benefits of Combination Contraceptives von Roederer, Mary W, Blackwell, Jean C, Blenning, Carol

Volltext

What are the relative risks and benefits of progestin-only contraceptives? von Roederer, Mary W, Blackwell, Jean C

Volltext

Reply: Global Formulary Review: How Do We Integrate Pharmacogenomic Information? von Poppe, Lindsey B, Roederer, Mary W

Volltext

Can pharmacogenomics improve malaria drug policy?/a pharmacogenomique peut- elle ameliorer la politique des medicaments contre le paludisme?/?Puede mejorar la farmacogenomica la po... von Roederer, Mary W, McLeod, Howard, Juliano, Jonathan J

Volltext

Use of pharmacogenomic information results in clinical benefits von Roederer, Mary W.

Volltext

FPIN's Clinical inquiries. Risks and benefits of combination contraceptives von Roederer, Mary W, Blackwell, Jean C

Volltext

Many people have CYP gene variations associated with severe drug interactions von Roederer, Mary W.

Volltext

Clinical inquiries. What are the relative risks and benefits of progestin-only contraceptives? von Roederer, Mary W, Blackwell, Jean C, Crawford, Paul

Volltext

Polymorphism of ORM1 Is Associated with the Pharmacokinetics of Telmisartan. e70341 von Chen, Wang-Qing, Shu, Yan, Li, Qing, Xu, Lin-Yong, Roederer, Mary W, Fan, Lan, Wu, Lan-Xiang, He, Fa-Zhong, Luo, Jian-Quan, Tan, Zhi-Rong

Volltext

Making pharmacogenetic testing a reality in a community pharmacy von O’Connor, Shanna K., PharmD, BCPS, Ferreri, Stefanie P., PharmD, CPP, BCACP, CDE, FAPhA, Michaels, Natasha M., PharmD, CPP, Chater, Rebecca W., BSPharm, MPH, FAPhA, Viera, Anthony J., MD, MPH, Faruki, Hawazin, McLeod, Howard L., PharmD, FCCP, Roederer, Mary

Volltext